Status:
COMPLETED
A Study of a Probiotic in Atopic Dermatitis
Lead Sponsor:
Chungbuk National University
Collaborating Sponsors:
Yeungnam University Hospital
Korea Research Institute of Bioscience & Biotechnology
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
2-10 years
Phase:
PHASE3
Brief Summary
The aim of this study was to assess the clinical effect of Lactobacillus sakei supplementation in children with atopic dermatitis.
Detailed Description
Probiotics were also shown to reduce severity of AEDS when administered to infants with early onset AEDS. In contrast, only a few studies have evaluated the therapeutic effectiveness of probiotics on ...
Eligibility Criteria
Inclusion
- patients with atopic dermatitis present for at least 6 months before inclusion
- a total SCORAD score above 25
- a change in a total SCORAD score of not more than 10% within 2 weeks
Exclusion
- patients who had been treated with cyclosporine, systemic steroid, topical calcineurin inhibitor, or Chinese herbal medicine during the preceding 3 months
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT00893230
Start Date
January 1 2007
End Date
November 1 2008
Last Update
May 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chungbuk National University Hospital
Cheongju-si, South Korea, 361-711